Tungsiripat, M., El-Bejjani, D., Rizk, N., Dogra, V., O'Riordan, M. A., Ross, A. C., . . . McComsey, G. A. (2011). Carotid Intima Media Thickness, Inflammatory Markers, and Endothelial Activation Markers in HIV Patients with Lipoatrophy Increased at 48 Weeks Regardless of Use of Rosiglitazone or Placebo. Mary Ann Liebert, Inc.
Citação norma ChicagoTungsiripat, Marisa, et al. Carotid Intima Media Thickness, Inflammatory Markers, and Endothelial Activation Markers in HIV Patients With Lipoatrophy Increased At 48 Weeks Regardless of Use of Rosiglitazone or Placebo. Mary Ann Liebert, Inc, 2011.
MLA引文Tungsiripat, Marisa, et al. Carotid Intima Media Thickness, Inflammatory Markers, and Endothelial Activation Markers in HIV Patients With Lipoatrophy Increased At 48 Weeks Regardless of Use of Rosiglitazone or Placebo. Mary Ann Liebert, Inc, 2011.